Publicacions
-
Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, Bueno C, Mora J, Peinado H, Segovia JC, Menendez P and Rodriguez-Perales S.
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
NATURE COMMUNICATIONS . 11(1): 5060-5060. Nº de cites: 76
-
Moisés J, Navarro A, Castellano JJ, Viñolas N, Molins L, Canals J, Han B, Martin-Serrano J, Ramirez J, Frigola G, Marrades RM and Monzó M.
Long Non-Coding RNA NANCI/NKX2-1 Duplex Impacts Prognosis in Stage I Non-Small-Cell Lung Cancer.
ARCHIVOS DE BRONCONEUMOLOGIA . 56(10): 630-636. Nº de cites: 3
-
Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
Science Advances . 6(43): 3058. Nº de cites: 27
-
Tejo-Otero A, Lustig-Gainza P, Fenollosa-Artés F, Valls-Esteve A, Krauel L and Buj-Corral I.
3D printed soft surgical planning prototype for a biliary tract rhabdomyosarcoma
Journal of the mechanical behavior of biomedical materials . 109: 103844-103844. Nº de cites: 28
-
Gadea A, Hernandez-Muñoz MI, Vicente-Villa MA, Andrades E, García-Calvente M, Camacho L, Fernandez-Rodríguez C, Bellosillo B, Pujol R and Toll A.
Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi.
JOURNAL OF MEDICAL GENETICS . 57(9): 601-604. Nº de cites: 3
-
Herrero A, Yoshii T, Ispizua JI, Colque C, Veenstra JA, Muraro NI and Ceriani MF.
Coupling Neuropeptide Levels to Structural Plasticity in Drosophila Clock Neurons.
CURRENT BIOLOGY . 30(16): . Nº de cites: 25
-
Alcon C, Manzano-Muñoz A, Prada-Varela E, Mora J, Soriano A, Guillén G, Gallego S, Roma J, Samitier J, Villanueva A and Montero J.
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance
CELL DEATH & DISEASE . 11(8): 634-634. Nº de cites: 19
-
Castillo H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Parés C, Burgeño-Sandoval V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Santa-María López V, Roldan-Molina M, Suñol M, de Alava E, Mora J, Lavarino C and Carcaboso AM.
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution
JOURNAL OF CONTROLLED RELEASE . 324: 440-449. Nº de cites: 8
-
Bossacoma F, Cuadrado-Vilanova M, Vinent-Genestar J, Correa MG, Gavrus D, Castillo H, Català-Mora J, Mora J, Schaiquevich P, Chantada G and Carcaboso AM.
Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection
OPHTHALMIC GENETICS . 41(4): 397-400. Nº de cites: 3
-
Fernández-Rodríguez J, Morales-La Madrid A, Gel B, Castañeda-Heredia A, Salvador-Hernandez H, Martínez-Iniesta M, Moutinho C, Morata J, Heyn H, Blanco I, Creus-Bachiller E, Capella G, Farré L, Vidal A, Soldado F, Krauel L, Suñol M, Serra E, Villanueva A and Lázaro C.
Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 12: . Nº de cites: 6
